Member database | CDD |
CDD type | domain |
Short name | FYVE_CARP1 |
Set | FYVE_like_SF |
Description
References
1.High hRFI expression correlates with resistance to fluoropyrimidines in human colon cancer cell lines and in xenografts. Sasaki S, Watanabe T, Kobunai T, Konishi T, Kitayama J, Nagawa H. J Exp Clin Cancer Res 24, 397-403, (2005). PMID: 16270526
2.Overexpression of hRFI (human ring finger homologous to inhibitor of apoptosis protein type) inhibits death receptor-mediated apoptosis in colorectal cancer cells. Konishi T, Sasaki S, Watanabe T, Kitayama J, Nagawa H. Mol Cancer Ther 4, 743-50, (2005). PMID: 15897238
3.Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL. Konishi T, Sasaki S, Watanabe T, Kitayama J, Nagawa H. Oncogene 25, 3160-9, (2006). PMID: 16407826
4.Isolation and characterization of a novel gene, hRFI, preferentially expressed in esophageal cancer. Sasaki S, Nakamura T, Arakawa H, Mori M, Watanabe T, Nagawa H, Croce CM. Oncogene 21, 5024-30, (2002). PMID: 12118383
5.Diffuse expression of hRFI is correlated with blood vessel invasion in gastric carcinoma. Sasaki S, Kitayama J, Watanabe T, Konishi T, Nagawa H. Jpn J Clin Oncol 34, 584-7, (2004). PMID: 15591455
6.Exogenous expression of hRFI induces multidrug resistance through escape from apoptosis in colorectal cancer cells. Konishi T, Sasaki S, Watanabe T, Kitayama J, Nagawa H. Anticancer Res 25, 2737-41, (2005). PMID: 16080519
7.Effects of expression of hRFI on adenoma formation and tumor progression in colorectal adenoma-carcinoma sequence. Sasaki S, Watanabe T, Konishi T, Kitayama J, Nagawa H. J Exp Clin Cancer Res 23, 507-12, (2004). PMID: 15595643
8.Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth. McDonald ER 3rd, El-Deiry WS. Proc Natl Acad Sci U S A 101, 6170-5, (2004). PMID: 15069192